Epigenetic alterations of krüppel-like factor 4 and its tumor suppressor function in renal cell carcinoma

Carcinogenesis

Volumn 34, Issue 10, 2013, Pages 2262-2270

  Li, Heng ^a   Wang, Ji ^b   Xiao, Wei ^a   Xia, Ding ^a   Lang, Bin ^c   Yu, Gan ^a   Guo, Xiaolin ^a   Guan, Wei ^a   Wang, Zhihua ^a   Hu, Zhiquan ^a   Liu, Jihong ^a   Ye, Zhangqun ^a   Xu, Hua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MACAO POLYTECHNIC INSTITUTE   (Macao)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER PROGNOSIS; CARCINOGENICITY; CELL GROWTH; CELL MIGRATION; DOWN REGULATION; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; KIDNEY CARCINOMA; KIDNEY METASTASIS; KIDNEY PARENCHYMA; KRUPPEL LIKE FACTOR 4 GENE; MAJOR CLINICAL STUDY; MALE; METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 84885137662     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt189     Document Type: Article

References (42)

1. Schrader, A.J. et al. (2008) Gender-specific characteristics and survival of renal cell carcinoma. Urologe. A, 47, 1182, 1184-1186.
2. Bukowski, R.M. (2009) Prognostic factors for survival in metastatic renal cell carcinoma: update 2008. Cancer, 115(suppl. 10), 2273-2281.
3. Yan, B.C. et al. (2009) Recent developments in the pathology of renal tumors: morphology and molecular characteristics of select entities. Arch. Pathol. Lab. Med., 133, 1026-1032.
4. Wei, D. et al. (2005) Drastic down-regulation of Krüppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res., 65, 2746-2754.
5. Zhao, W. et al. (2004) Identification of Krüppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene, 23, 395-402.
6. Wei, D. et al. (2008) Kruppel-like factor 4 induces p27Kip1 expression in and suppresses the growth and metastasis of human pancreatic cancer cells. Cancer Res., 68, 4631-4639.
7. Yang, Y. et al. (2005) KLF4 and KLF5 regulate proliferation, apoptosis and invasion in esophageal cancer cells. Cancer Biol. Ther., 4, 1216-1221.
8. Hu, W. et al. (2009) Putative tumor-suppressive function of Kruppel-like factor 4 in primary lung carcinoma. Clin. Cancer Res., 15, 5688-5695.
9. Wang, J. et al. (2010) Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration. Cancer Res., 70, 10182-10191.
10. Li, Q. et al. (2012) Dysregulated Krüppel-like factor 4 and vitamin D receptor signaling contribute to progression of hepatocellular carcinoma. Gastroenterology, 143, 799-810.e1.
11. Katz, J.P. et al. (2002) The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development, 129, 2619-2628.
12. Ghaleb, A.M. et al. (2007) Haploinsufficiency of Krüppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis. Cancer Res., 67, 7147-7154.
13. Katz, J.P. et al. (2005) Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach. Gastroenterology, 128, 935-945.
14. Yoon, H.S. et al. (2004) Requirement of Krüppel-like factor 4 in preventing entry into mitosis following DNA damage. J. Biol. Chem., 279, 5035-5041.
15. Foster, K.W. et al. (2000) Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Cancer Res., 60, 6488-6495.
16. Huang, C.C. et al. (2005) KLF4 and PCNA identify stages of tumor initiation in a conditional model of cutaneous squamous epithelial neoplasia. Cancer Biol. Ther., 4, 1401-1408.
17. Foster, K.W. et al. (1999) Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF. Cell Growth Differ., 10, 423-434.
18. Li, L.C. et al. (2006) Small dsRNAs induce transcriptional activation in human cells. Proc. Natl Acad. Sci. USA, 103, 17337-17342.
19. Janowski, B.A. et al. (2007) Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. Nat. Chem. Biol., 3, 166-173.
20. Place, R.F. et al. (2008) MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc. Natl Acad. Sci. USA, 105, 1608-1613.
21. Place, R.F. et al. (2010) Defining features and exploring chemical modifications to manipulate RNAa activity. Curr. Pharm. Biotechnol., 11, 518-526.
22. Huang, V. et al. (2010) RNAa is conserved in mammalian cells. PLoS One, 5, e8848.
23. Wang, L. et al. (2010) Relation between hypomethylation of long interspersed nucleotide elements and risk of neural tube defects. Am. J. Clin. Nutr., 91, 1359-1367.
24. Saini, S. et al. (2011) MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. Cancer Res., 71, 6208-6219.
25. Liu, C. et al. (2011) The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat. Med., 17, 211-215.
26. Parhar, R.S. et al. (1987) Amelioration of B16F10 melanoma lung metastasis in mice by a combination therapy with indomethacin and interleukin 2. J. Exp. Med., 165, 14-28.
27. Nakahara, Y. et al. (2010) Genetic and epigenetic inactivation of Kruppellike factor 4 in medulloblastoma. Neoplasia, 12, 20-27.
28. Chen, X. et al. (2001) Krüppel-like factor 4 (gut-enriched Krüppel-like factor) inhibits cell proliferation by blocking G1/S progression of the cell cycle. J. Biol. Chem., 276, 30423-30428.
29. Zhang, W. et al. (2000) The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter. J. Biol. Chem., 275, 18391-18398.
30. Shie, J.L. et al. (2000) Gut-enriched Krüppel-like factor represses cyclin D1 promoter activity through Sp1 motif. Nucleic Acids Res., 28, 2969-2976.
31. Ohnishi, S. et al. (2003) Downregulation and growth inhibitory effect of epithelial-type Krüppel-like transcription factor KLF4, but not KLF5, in bladder cancer. Biochem. Biophys. Res. Commun., 308, 251-256.
32. Chen, Z.Y. et al. (2000) Up-regulation of gut-enriched krüppel-like factor by interferon-gamma in human colon carcinoma cells. FEBS Lett., 477, 67-72.
33. Yasunaga, J. et al. (2004) Identification of aberrantly methylated genes in association with adult T-cell leukemia. Cancer Res., 64, 6002-6009.
34. Dang, D.T. et al. (2003) Overexpression of Krüppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecity. Oncogene, 22, 3424-3430.
35. Hagos, E.G. et al. (2009) Mouse embryonic fibroblasts null for the Krüppellike factor 4 gene are genetically unstable. Oncogene, 28, 1197-1205.
36. Yori, J.L. et al. (2011) Krüppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer. Neoplasia, 13, 601-610.
37. Li, R. et al. (2010) A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell, 7, 51-63.
38. Brinster, R.L. et al. (1988) Introns increase transcriptional efficiency in transgenic mice. Proc. Natl Acad. Sci. USA, 85, 836-840.
39. Clark, A.J. et al. (1993) Enhancing the efficiency of transgene expression. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 339, 225-232.
40. Zufferey, R. et al. (1997) Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol., 15, 871-875.
41. Naldini, L. et al. (1996) Efficient transfer, integration, and sustained longterm expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl Acad. Sci. USA, 93, 11382-11388.
42. Ramezani, A. et al. (2000) Lentiviral vectors for enhanced gene expression in human hematopoietic cells. Mol. Ther., 2, 458-469.